NIKA PHARMACEUTICALS, INC (NIKA) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$76.4K | +20.2% |
| 2024 | -$95.8K | -47.8% |
| 2023 | -$64.8K | +98.0% |
| 2022 | -$3.18M | -21540.3% |
| 2021 | -$14.7K | -65.2% |
| 2020 | -$8.9K | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$76.4K | +20.2% |
| 2024 | -$95.8K | -47.8% |
| 2023 | -$64.8K | +98.0% |
| 2022 | -$3.18M | -21540.3% |
| 2021 | -$14.7K | -65.2% |
| 2020 | -$8.9K | — |